Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 6:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 217–240 of 617 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Oral Supplement Clear all

Conditions: Wheezing
Interventions: Soy Isoflavone Nutritional Supplements; Drug
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 4 Months to 24 Months
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cardiovascular Risk Factor, Obesity
Interventions: High Intensity Interval Training, Essential Amino Acid, High intensity interval training and essential amino acid supplement; Other · Dietary Supplement
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 30 Years to 50 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Prostate Cancer, Multiple Myeloma, Smoldering Multiple Myeloma (SMM), Monoclonal Gammopathy of Undetermined Significance
Interventions: Curcumin plus Piperine; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Anthracycline Related Cardiotoxicity in Breast Cancer
Interventions: sulforaphane, Placebo Oral Tablet; Drug
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 18 Years to 89 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Androgenetic Alopecia, Androgenic Alopecia, Telogen Effluvium, Thinning Hair, Hair Loss/Baldness, Hair Thinning
Interventions: ALRV5XR, ALRV5XR Shampoo, ALRV5XR Conditioner, ALRV5XR Hair Follicle Serum (Nutriment), Placebo, Placebo Shampoo, Placebo Conditioner, Placebo Hair Follicle Serum (Nutriment); Dietary Supplement · Other
Lead sponsor: Arbor Life Labs; Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Melanoma
Interventions: VESANOID, Ipilimumab; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 89 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2023
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Surgical Recovery
Interventions: CocoaVia®, Placebo; Drug · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Stanford, California

Conditions: Polycystic Ovarian Syndrome, Obesity, Hepatic Steatosis
Interventions: Essential Amino Acid (EAA) Supplement, Placebo; Dietary Supplement · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 12 Years to 21 Years · Female only
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Congenital Disorders of Glycosylation
Interventions: D-Galactose; Dietary Supplement
Lead sponsor: Tulane University; Other
Eligibility: Up to 21 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Healthy
Interventions: Oral amino acid tracer; Other
Lead sponsor: University of Arkansas; Other
Eligibility: 21 Years to 40 Years
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Adolescent Idiopathic Scoliosis, Neuromuscular Scoliosis, Perioperative/Postoperative Complications, Iron Deficiencies, Anemia, Spinal Fusion, Postoperative Cognitive Dysfunction
Interventions: Oral ferrous sulfate, Oral placebo tablet; Dietary Supplement
Lead sponsor: Columbia University; Other
Eligibility: 10 Years to 26 Years
Enrollment: 275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: COPD, Obstructive Lung Disease
Interventions: Lactobacillus GG, Sugar pill; Dietary Supplement · Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 99 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Healthy Subjects
Interventions: oral spermidine; Dietary Supplement
Lead sponsor: Chrysea Labs Lda; Industry
Eligibility: 50 Years to 70 Years · Male only
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Addison, Illinois

Conditions: Womens Health, Menstrual Symptoms
Interventions: Effera® (human equivalent lactoferrin), Placebo; Dietary Supplement · Other
Lead sponsor: Helaina Inc.; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Blood Pressure
Interventions: Provex CV, placebo; Drug · Other
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Diabetes, Diabetic Retinopathy
Interventions: DVS supplementation; Dietary Supplement
Lead sponsor: ZeaVision, LLC; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 2
States / cities: Pomona, California • Tahlequah, Oklahoma

Conditions: Hyperinsulinism-Hyperammonemia Syndrome
Interventions: Vitamin E; Dietary Supplement
Lead sponsor: Elizabeth A Rosenfeld; Other
Eligibility: 1 Year to 40 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Depression
Interventions: pregnenolone, placebo; Dietary Supplement · Other
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 40 Years to 60 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acne
Interventions: Skin Nutraceutical Supplement, Placebo pill; Dietary Supplement · Other
Lead sponsor: Nutraceutical Wellness Inc.; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: High Point, North Carolina

Conditions: Gingivitis
Interventions: Functional Chitosan Chewing Gum, Control Chewing Gum, Oral hygiene measures; Device · Behavioral
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease, Overweight and Obesity
Interventions: Insulin human, Octreotide Acetate, Glucagon, Human Growth Hormone, Dexamethasone Oral, [6,6-2H2] D-glucose, 20% D-glucose (aq), BOOST Plus, Harvard Apparatus PHD ULTRA CP syringe pump, Yellow Springs Instruments (YSI) 2500 Biochemistry Glucose/Lactate Analyzer, Normal saline, Human albumin; Drug · Other · Dietary Supplement + 1 more
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Community-Acquired Staphylococcus Aureus
Interventions: Routine Measures Group, Bleach Bath Group (Bleach plus routine measures); Procedure
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 3 Months to 18 Years
Enrollment: 987 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Gulf War Syndrome, Persian Gulf Syndrome, Mitochondrial Disorder, Respiratory Chain
Interventions: PharmaNord Bio-Quinone Active CoQ10 Gold 100mg, PharmaNord Placebo; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 50 Years and older
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Healthy
Interventions: Low oxalate controlled Diet, Primed, continuous intravenous infusion of 13C2-Glycolate, Bolus intravenous infusion of 13C2-Glycolate, Oral bolus administration of 13C2-Glycolate; Dietary Supplement · Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 75 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Birmingham, Alabama

Search by objective public record fields.

Genes, Soy Isoflavones, and Virus

Essential Amino Acids and High Intensity Interval Training

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss

Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma

Cocoa Flavanols for Modulating Immune Response and Accelerating Recovery

Oral Amino Acid Nutrition to Improve Glucose Excursions in PCOS

Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation

Whole Body Protein Metabolism of a Whey/EAA Supplement Using Continuous Oral Stable Isotopes

Kids With Iron Deficiency and Scoliosis

Probiotic Use in Patients With Prior COPD Exacerbation

Metabolic Responses to Spermidine Supplementation.

Effera Dose Response: Women's Health

Efficacy of Provex CV Supplement to Reduce Inflammation Cytokines and Blood Pressure

Diabetic Retinopathy Functional Evaluation Study: Monitoring Carotenoid Vitamins Treatment Using ERG

Vitamin E Supplementation in Hyperinsulinism/Hyperammonemia Syndrome

Study on Allopregnanolone and Depression in Women Across the Menopause Transition

RCT of an Oral Acne Supplement for Adult Women

Functional Chewing Gum in Reduction of Gingival Inflammation

Dexamethasone/Pancreatic Clamp P&F

Prevention of Recurrent Infections Caused by Community Acquired Staphylococcus Aureus (CA-SA) in Children

Coenzyme Q10 for Gulf War Illness: A Replication Study

Renal Metabolism of Glycolate to Oxalate